Cargando…

Four New Monoterpenoid Glycosides from the Flower Buds of Magnolia biondii

Four new monoterpenoid glycosides 1–4, named magnoliaterpenoid A–D, were isolated from a 50% aqueous acetone extract of flower buds of Magnolia biondii, along with one known compound, (1′R,3′S,5′R,8′S,2Z,4E)-dihydrophaseic acid 3-O-β-d-glucopyranoside (5). Their structures and relative configuration...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wei-Sheng, He, Yu-Huan, Zheng, Xiao-Ke, Wang, Jian-Chao, Cao, Yan-Gang, Zhang, Yan-Li, Song, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274139/
https://www.ncbi.nlm.nih.gov/pubmed/27271584
http://dx.doi.org/10.3390/molecules21060728
Descripción
Sumario:Four new monoterpenoid glycosides 1–4, named magnoliaterpenoid A–D, were isolated from a 50% aqueous acetone extract of flower buds of Magnolia biondii, along with one known compound, (1′R,3′S,5′R,8′S,2Z,4E)-dihydrophaseic acid 3-O-β-d-glucopyranoside (5). Their structures and relative configuration were identified by extensive spectroscopic analysis (IR, UV, MS, 1D and 2D NMR). The aglycones of these four new compounds possess seven-membered rings systems, which are very rare. A plausible biosynthetic route for the four new compounds was proposed via the biogenetic isoprene rule. Compounds 1, 2, 3, and 4 showed no antimicrobial activity at the concentration range of 1.95–250 µg/mL.